Abstract
Recent advances in molecular genetics have established a molecular basis for persistent hyperinsulinemic hypoglycemia of infancy (PHHI) and resulted in the identification of a number of well-defined genetic defects. On the basis of the available information on the molecular changes so far described, an attempt has been made to classify PHHI patients according to their genotype and phenotype, with reference to molecular genetics, pancreatic pathology and clinical appearance. This classification has resulted in the differentiation of three groups of PHHI patients, two with diffuse beta cell hyperfunction and one with focal beta cell hyperfunction.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 22 September 1999 / Accepted: 5 October 1999
Rights and permissions
About this article
Cite this article
Reinecke-Lüthge, A., Koschoreck, F. & Klöppel, G. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virchows Archiv 436, 1–5 (2000). https://doi.org/10.1007/PL00008192
Issue Date:
DOI: https://doi.org/10.1007/PL00008192